Hermetica Superfood Encyclopedia
The Short Answer
Monoamine Oxidase B (MAO-B) is a mitochondrial enzyme that metabolizes dopamine, phenylethylamine, and other monoamines in the brain. This enzyme plays a crucial role in neurotransmitter regulation, cognitive function, and neuroprotection through its control of dopaminergic signaling pathways.
CategoryEnzyme
GroupMetabolic Enzyme
Evidence LevelStrong
Primary KeywordMAO-B enzyme benefits
Synergy Pairings4
Monoamine Oxidase B (MAO-B) — botanical close-up
Health Benefits
Supports cognitive function and memory by breaking down dopamine, a neurotransmitter essential for focus and recall. - Regulates mood and emotional well-being by modulating dopamine and phenylethylamine levels, reducing risk of mood disorders. - Influences neuroprotection, as MAO-B inhibition has been shown to slow neurodegeneration by up to 40% in Parkinson’s studies. - Enhances alertness and motivation by optimizing dopamine availability in the brain. - May reduce oxidative stress by limiting the formation of neurotoxic byproducts during neurotransmitter breakdown. - Supports healthy aging by preserving cognitive function and mental agility. - Aids in managing symptoms of neurodegenerative diseases by maintaining neurotransmitter balance. - Promotes emotional resilience by stabilizing mood-related biochemicals.
Origin & History
Natural habitat
Monoamine Oxidase B (MAO-B) is a metabolic enzyme that breaks down monoamines, including neurotransmitters like dopamine. It is found in the brain and other tissues, playing a role in mood regulation and neurotransmitter metabolism.
“Identified in the 20th century, MAO-B has been studied for its role in neurological health and aging.”Traditional Medicine
Scientific Research
Human trials and observational studies have explored its role in neurodegenerative diseases and mood disorders.
Preparation & Dosage
Traditional preparation
No direct supplementation; modulation through diet and lifestyle choices. Consult a healthcare provider before use.
Nutritional Profile
- Flavin-containing enzyme.
- Breaks down monoamine neurotransmitters.
- Involved in dopamine metabolism.
How It Works
Mechanism of Action
MAO-B catalyzes the oxidative deamination of dopamine, phenylethylamine, and benzylamine using FAD as a cofactor, producing aldehydes, ammonia, and hydrogen peroxide. The enzyme is primarily located in astrocytes and increases with age, leading to enhanced dopamine metabolism. MAO-B inhibition preserves dopamine levels in the synaptic cleft, enhancing dopaminergic neurotransmission and potentially protecting against neurodegeneration.
Clinical Evidence
Clinical studies on MAO-B inhibitors like selegiline and rasagiline demonstrate neuroprotective effects in Parkinson's disease patients, with trials showing 20-30% reduction in disease progression markers. A 5-year study of 800 early Parkinson's patients found MAO-B inhibitor treatment delayed need for levodopa therapy by 9 months. Research indicates MAO-B activity increases 4-6 fold with aging, correlating with cognitive decline. However, most evidence focuses on pharmaceutical MAO-B inhibitors rather than natural enzyme modulation, limiting conclusions about supplemental approaches.
Safety & Interactions
MAO-B inhibitors can cause serious interactions with tyramine-rich foods, leading to hypertensive crises, though this risk is lower than with MAO-A inhibitors. Common side effects include insomnia, dizziness, and nausea, occurring in 10-15% of users. Contraindications include concurrent use with meperidine, tramadol, and certain antidepressants due to serotonin syndrome risk. Pregnant and breastfeeding women should avoid MAO-B modulators due to insufficient safety data and potential effects on fetal neurotransmitter development.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the difference between MAO-A and MAO-B enzymes?
MAO-A primarily metabolizes serotonin, norepinephrine, and epinephrine, while MAO-B specifically targets dopamine, phenylethylamine, and benzylamine. MAO-A is found in neurons and peripheral tissues, whereas MAO-B is predominantly located in astrocytes and increases significantly with aging.
How does MAO-B activity change with age?
MAO-B activity increases 4-6 fold between ages 20-80, leading to enhanced dopamine breakdown and potentially contributing to age-related cognitive decline. This age-related increase occurs primarily in glial cells and may explain why dopaminergic function deteriorates with aging.
Can natural compounds inhibit MAO-B enzyme?
Yes, natural compounds like curcumin, resveratrol, and green tea catechins show MAO-B inhibitory activity in laboratory studies. However, their potency is significantly lower than pharmaceutical inhibitors like selegiline, and clinical effectiveness for neuroprotection remains unproven.
What foods should be avoided with MAO-B inhibitors?
High-tyramine foods like aged cheeses, cured meats, fermented products, and red wine should be limited but are less problematic with MAO-B inhibitors than MAO-A inhibitors. The tyramine restriction is generally milder, but monitoring blood pressure is still recommended when consuming these foods.
How long do MAO-B inhibitors take to show effects?
MAO-B inhibition occurs within hours of administration, but clinical benefits in conditions like Parkinson's disease typically emerge after 4-8 weeks of consistent use. Maximum enzyme inhibition (80-90%) is usually achieved within 2-4 weeks of starting treatment at therapeutic doses.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
